4.7 Article

Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Management of advanced prostate cancer after first-line chemotherapy

DR Berthold et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Urology & Nephrology

Satraplatin in the treatment of hormone-refractory prostate cancer

CN Sternberg

BJU INTERNATIONAL (2005)

Article Medicine, General & Internal

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

DP Petrylak et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

IF Tannock et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Oncology

What's new in the treatment of advanced prostate cancer?

CN Sternberg

EUROPEAN JOURNAL OF CANCER (2003)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)